## XYL: Xylem Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -1.1% below STRENGTH zone (4.0-10.0%); PEG 2.14 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($133.15)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Who Owns Xylem? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251217T130827 | Neutral | Relevance: 100%
- This article details the major shareholders of Xylem Inc. (NYSE: XYL), a global water technology company, highlighting that its ownership is primarily anchored by large passive institutions like Vanguard and BlackRock. It also examines recent insider trading activities, which appear modest and mixed, alongside selective hedge fund accumulation. The overall sentiment suggests Xylem is viewed as a stable infrastructure business with cautious investment at current valuations.

**2. Thurston Springer Miller Herd & Titak Inc. Sells 18,715 Shares of Xylem Inc. $XYL**
- Source: MarketBeat | 20251217T142716 | Somewhat-Bullish | Relevance: 100%
- Thurston Springer Miller Herd & Titak Inc. significantly reduced its stake in Xylem Inc. (NYSE:XYL) by 91.7%, selling 18,715 shares and retaining 1,691 shares. Despite this sell-off, Xylem beat Q3 earnings and revenue estimates, provided strong FY2025 guidance, and holds a "Moderate Buy" consensus analyst rating with a target of $167.40. The article also details other institutional investment changes and insider selling by Xylem executives.

**3. Ultraviolet (UV) Disinfection Equipment Market Is Going to Boom |• Xylem Inc. • Trojan Technologies**
- Source: openPR.com | 20251219T090856 | Bullish | Relevance: 100%
- Worldwide Market Reports has released a new research study predicting substantial growth for the Ultraviolet (UV) Disinfection Equipment Market. The comprehensive report analyzes market dynamics, drivers, restraints, challenges, and opportunities, providing insights into various applications such as water treatment, air purification, and healthcare facility sanitation. It also profiles key players like Xylem Inc. and Trojan Technologies and offers regional growth forecasts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | TD Cowen | $135 | $130 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | TD Cowen | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.7%)
- Blackrock Inc.: 10.2% (+1.6%)
- State Street Corpora: 4.5% (+1.2%)
- Geode Capital Manage: 2.5% (+1.1%)
- Impax Asset Manageme: 2.2% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.14 elevated, pricing in significant growth expectations. Forward P/E 24.8x stretched relative to 10% growth. Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $33.6B |
| Beta | 1.17 |
| 52W Range | $100.47 - $154.27 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.14 |
| Forward P/E | 24.8 |
| Current P/E | 27.3 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -1.1% (minimal 5-day change). Below STRENGTH zone by 5.1pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). RSI neutral at 42. OFD pattern: +FTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.12% (CS: 38) | Neutral |
| RSI_14 | 42.4 | Neutral |
| MACD Histogram | 0.08 | Bullish |
| vs SMA20 | 0.992x | Below |
| vs SMA50 | 0.959x | Below |
| vs SMA200 | 1.034x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $138.03
- **Stop Loss:** $133.15 (3.5% risk)
- **Target:** $142.91 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 184
- **Position Value:** $25,397.52
- **Portfolio %:** 25.40%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-03 (Est: $1.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.37 | +11.1% |
| 2025Q2 | $1.15 | $1.26 | +9.9% |
| 2025Q1 | $0.95 | $1.03 | +8.0% |
| 2024Q4 | $1.13 | $1.18 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*